Cite
MLA Citation
B Olshansky et al.. “Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial).” European heart journal, vol. 42, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100144497575.0x000036